Filter
1196
Text search:
human
pharmaceutical
products
Featured
Recommendations
113
New Publications
332
Language
Document type
No document type
603
Studies & Reports
242
Guidelines
179
Manuals
67
Strategic & Response Plan
63
Training Material
15
Fact sheets
13
Situation Updates
8
Resource Platforms
4
Brochures
1
Infographics
1
Countries / Regions
Kenya
60
Global
44
Ethiopia
42
India
37
Nigeria
27
South Africa
26
Western and Central Europe
26
Uganda
24
Sierra Leone
23
Liberia
23
Rwanda
22
Ghana
19
Zambia
18
Tanzania
18
Ukraine
17
Namibia
16
Philippines
15
Nepal
14
Africa
13
Malawi
12
Eastern Europe
12
Zimbabwe
11
Indonesia
11
Bangladesh
11
Latin America and the Carribbean
11
Lesotho
9
Myanmar / Burma
9
Eswatini/ Swaziland
8
West and Central Africa
7
Burkina Faso
6
Syria
6
Botswana
6
Eastern Europe and Central Asia
6
Asia
6
Cambodia
5
East and Southern Africa
5
Senegal
4
Congo, Democratic Republic of
4
Cameroon
4
Haiti
4
South–East Asia Region
4
Guinea
3
Jordan
3
Thailand
3
Mozambique
3
Sudan
3
North Macedonia
3
Venezuela
3
Russia
3
North America
3
Mali
2
USA
2
Pakistan
2
South Sudan
2
China
2
Benin
2
Central African Republic
2
Brazil
2
Middle East and North Africa
2
Fiji
2
Albania
2
Laos
2
Moldova
2
Kyrgyzstan
2
Georgia
2
Jamaica
2
Saudi Arabia
1
Niger
1
Somalia
1
Iraq
1
Afghanistan
1
Germany
1
Lebanon
1
Egypt
1
Papua New Guinea
1
Serbia
1
Libya
1
Madagascar
1
Western Pacific Region
1
Armenia
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Vietnam
1
Gabon
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
493
Clinical Guidelines
90
Public Health
60
Key Resources
47
Women & Child Health
31
Pharmacy & Technologies
23
Capacity Building
8
Annual Report MEDBOX
1
Toolboxes
AMR
157
Pharmacy
129
COVID-19
72
TB
57
HIV
49
Mental Health
47
Rapid Response
41
Planetary Health
38
Global Health Education
25
Conflict
22
NCDs
21
Caregiver
20
NTDs
19
Ebola
16
Health Financing Toolbox
14
Disability
9
Refugee
7
Specific Hazards
6
Polio
5
Natural Hazards
5
Zika
3
Health Financing
1
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga
...
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List
...
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tuberculosis, acute respiratory infections, diar
...
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many
...
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs
...
The “United Nations Framework for the immediate socio-economic response to COVID-19: Shared responsibility, global solidarity and urgent action for people in need” calls for protecting jobs, businesses and livelihoods to set in motion a safe recovery of societies and economies as soon as possibl
...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
The WHO country office for Ghana, began the year 2019 with a 4-day staff retreat at the Busua Beach Resort in the Western Region from 04 to 08 March 2019. The theme for the retreat was ‘Impacting the Health and Lives of the people of Ghana through the Triple Billion Goal”. The staff outlined pri
...
Mental health is critical to personal well-being, interpersonal relationships, and successful contributions to society. Mental health conditions consequently impose a high burden not only on individuals, families and society, but also on economies. In Jamaica, mental health conditions are highly pre
...
Guidelines on the management of chronic pain in children, developing and implementing national and local policies for pain management and protocols in children, implementing national and local regulations for pain management in children, pain management and protocols
28 Dec 2020. The main objective of these guidelines is to provide tools for staff working in the field of immunization to support effective communication between health personnel and the general population, with the aim of strengthening, maintaining or recovering trust in vaccines and the immunizati
...
UNAIDS and the World Health Organization have published this updated guidance on ethical considerations in HIV prevention trials. The new guidance is the result of a year-long process that saw more than 80 experts and members of the public give inputs and is published 21 years after the first editio
...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we
...
The objective of this project was to list the medical devices required to provide the essential reproductive, maternal, newborn and child health interventions defined by existing WHO guidelines and publications, in order to improve access to these devices in low- and middle-income countries, support
...
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public health and the sound management of chemicals, described in section 1, and the opportunities provided by new technology. Assessments
...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti
...
